# Superconductivity in monolayer-trilayer phase of La$_3$Ni$_2$O$_7$ under high pressure

Preprint · Chaoxin Huang, Jingyuan Li, Xing Huang, Hengyuan Zhang, Deyuan Hu, Mengwu Huo, Xiang Chen, Zhen Chen, Hualei Sun, Meng Wang

- Archive id: arxiv:2510.12250
- Published: 2025-10-14
- Venue: Phys. Rev. X 16, 031072 (2026)
- DOI: https://doi.org/10.1103/jc35-gj2l
- arXiv: https://arxiv.org/abs/2510.12250
- Source URL: https://arxiv.org/abs/2510.12250
- PDF: https://arxiv.org/pdf/2510.12250
- Provenance: arxiv

## Abstract

The discovery of 80 K superconductivity in pressurized bilayer Ruddlesden-Popper (RP) nickelate La$\_3$Ni$\_2$O$\_7$ has established a new high-temperature superconductor family. The quest to understand the governing principles of RP nickelate superconductivity has become a central focus in condensed matter physics. Here, we report a critical advance by synthesizing and investigating a distinct structural polymorph of the same compound: the monolayer-trilayer (1313) hybrid phase of La$\_3$Ni$\_2$O$\_7$. Under high pressure, synchrotron X-ray diffraction and Raman spectroscopy reveal a structural transition from the orthorhombic $Cmmm$ to the tetragonal $P4/mmm$ space group at 13~GPa. Above 19 GPa, the phase exhibits a clear superconducting transition, confirmed by a zero-resistance state, albeit at a significantly reduced temperature of 3.6 K. The stark contrast with the 80 K transition in the bilayer phase provides a uniquely clean experimental comparison. Our results demonstrate that the superconducting transition temperature is directly governed by the nature of the interlayer coupling, and the bilayer NiO$\_6$ block as the essential structural motif for achieving high-$T\_\\text{c}$ superconductivity in the RP nickelates.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.